The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer
Official Title: Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer: A Prospective Exploratory Trial (POHIM_RT Trial)
Study ID: NCT03239626
Brief Summary: To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Samsung Medical Center, Seoul, , Korea, Republic of
Name: Won Park, M.D.,Ph.D
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR